Male Fertility Survey
ReproMed Ireland alongside Ferring Pharmaceuticals would like to better understand the patient profile and treatment pathway of men seeking treatment.
The data will be used to support the improvement of fertility treatments for male patients.
We are committed to ensuring that all data from this survey will be stored securely and may be securely shared with a 3rd party working for Ferring Pharmaceuticals in anonymised form. The data may subsequently be published in various channels which may include conferences, medical journals (printed and online) and on the Ferring Pharmaceuticals website.